Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation

Nature Medicine

Volumn 5, Issue 2, 1999, Pages 176-182

  Mason, Catherine A E ^a   Bigras, Jean Luc ^a,b   O'Blenes, Stacy B ^a   Zhou, Bin ^a   McIntyre, Brendan ^a   Nakamura, Norimasa ^c   Kaneda, Yasufumi ^c   Rabinovitch, Marlene ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOENGINEERING; CELL MIGRATION; FETUS; GENE TRANSFER; GESTATIONAL AGE; LAMB; MORPHOMETRICS; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA TRANSLATION; SMOOTH MUSCLE FIBER;

ANIMALS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DUCTUS ARTERIOSUS, PATENT; FEMALE; FIBRONECTINS; GENE THERAPY; GENETIC VECTORS; HEART DEFECTS, CONGENITAL; LIPOSOMES; MUSCLE, SMOOTH, VASCULAR; PLASMIDS; PREGNANCY; PROTEIN BIOSYNTHESIS; RESPIROVIRUS; RNA, MESSENGER; RNA-BINDING PROTEINS; SHEEP; TRANSFECTION;

ANIMALIA; OVIS ARIES;

EID: 0032925992     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/5538     Document Type: Article

References (31)

1. Silver, M.M., Freedom, R.M., Silver, M.D. & Olley, P.M. The morphology of the human newborn ductus arteriosus: A reappraisal of its structure and closure with special reference to prostaglandin E1 therapy. Hum. Pathol. 12, 1123-1136 (1981).
2. Gittenberger-de Groot, A.C., Strengers, J.L., Mentink, M., Poelmann, R.E. & Patterson, D.F. Histologic studies on normal and persistent ductus arteriosus in the dog. J. Am. Coll. Cardiol. 6, 394-404 (1985).
3. Gittenberger-de Groot, A.C., van Ertbruggen, I., Moulaert, A.J. & Harinck, E. The ductus arteriosus in the preterm infant: Histologic and clinical observations. J. Pediatr. 96, 88-93 (1980).
4. Gittenberger-de Groot, A.C., Moulaert, A.J. & Hitchcock, J.F. Histology of the persistent ductus arteriosus in cases of congenital rubella. Circulation 62, 183-186 (1980).
5. Olley, P.M., Coceani, F. & Bodach, E. E-type prostaglandins: A new emergency therapy for certain cyanotic congenital heart malformations. Circulation 53, 728-731 (1976).
6. Host, A., Halken, S., Kamper, J. & Lillquist, K. Prostaglandin E1 treatment in ductus dependent congenital cardiac malformation. A review of the treatment of 34 neonates. Dan. Med. Bull. 35, 81-84 (1988).
7. Hallidie, S.K. Prostaglandin E1 in suspected ductus dependent cardiac malformation. Arch. Dis. Child. 59, 1020-1026 (1984).
8. Boudreau, N. & Rabinovitch, M. Developmentally regulated changes in extracellular matrix in endothelial and smooth muscle cells in the ductus arteriosus may be related to intimal proliferation. Lab. Invest. 64, 187-199 (1991).
9. Boudreau, N., Turley, E. & Rabinovitch, M. Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev. Biol. 143, 235-247 (1991).
10. Boudreau, N., Clausell, N., Boyle, J. & Rabinovitch, M. Transforming growth factor-beta regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation. Lab. Invest. 67, 350-359 (1992).
11. Zhou, B., Boudreau, N., Coulber, C., Hammarback, J. & Rabinovitch, M. Microtubule-associated protein 1 light chain 3 is a fibronectin mRNA-binding protein linked to mRNA translation in lamb vascular smooth muscle cells. J. Clin. Invest. 100, 3070-3082 (1997).
12. Morishita, R. et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA 92, 5855-5859 (1995).
13. Yoder, M.J., Baumann, F.G., Grover, J.N., Brick, I. & Imparato, A.M. A morphological study of early cellular changes in the closure of the rabbit ductus arteriosus. Anat. Rec. 192, 19-39 (1978).
14. Hornblad, P.Y. Studies on closure of the ductus arteriosus. III. Species differences in closure rate and morphology. Cardiology 51, 262-282 (1967).
15. Kaneda, Y., Morishita, R. & Dzau, V.J. Prevention of restenosis by gene therapy. Ann. NY Acad. Sci. 811, 299-310 (1997).
16. Mann, M.J., Morishita, R., Gibbons, G.H., von der Leyen, H.E. & Dzau, V.J. DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes. Mol. Cell. Biochem. 172, 3-12 (1997).
17. Rome, J.J. et al. Adenoviral vector-mediated gene transfer into sheep arteries using a double-balloon catheter. Hum. Gene. Ther. 5, 1249-1258 (1994).
18. Zhou, B. & Rabinovitch, M. Microtubule involvement in translational regulation of fibronectin expression by light chain 3 of microtubule-associated protein 1 in vascular smooth muscle cells. Circ. Res. 83, 481-489 (1998).
19. Lemaitre, J.M., Buckle, R.S. & Mechali, M. c-Myc in the control of cell proliferation and embryonic development. Adv. Cancer Res. 70, 95-144 (1996).
20. Liebermann, D.A., Gregory, B. & Hoffman, B. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int. J. Oncol. 12, 685-700 (1998).
21. Brewer, G. An A+U-rich element RNA-binding factor regulates c-myc RNA stability in vitro. Mol Cell. Biol. 11, 2460-2466 (1991).
22. Chen, C.Y.A., Xu, N., Shyu, A.B. mRNA-decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol. Cell. Biol. 15, 5777-5788 (1995).
23. Veyrune, J.L., Hesketh, J. & Blanchard, J.M. 3′ untranslated regions of c-myc and c-fos mRNAs: multifunctional elements regulating mRNA translation, degradation and subcellular localization. Prog. Mol. Subcell. Biol. 18, 35-63 (1997).
24. Jones, P.L., Cowan, K.N. & Rabinovitch, M. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am. J. Pathol. 150, 1349-1360 (1997).
25. Botney, M.D. et al., Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries Am. J. Pathol. 140, 357-364 (1992).
26. Clausell, N. et al., Expression of tumour necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy. Br. Heart J. 73, 534-539 (1995).
27. Forsyth, E.A., Aly, H.M., Neville, R.F. & Sidawy, A.N. Proliferation and extracellular matrix production by human infragenicular smooth muscle cells in response to interleukin-1 beta. J. Vasc. Surg. 26, 1002-1008 (1997).
28. Sanders, M. Molecular and cellular concepts in atherosclerosis. Pharmacol. Ther. 61, 109-153 (1994).
29. Molossi, S., Clausell, N. & Rabinovitch, M. Coronary artery endothelial interleukin-1 beta mediates enhanced fibronectin production related to post-cardiac transplant arteriopathy in piglets. Circulation 248-256 (1993).
30. Molossi, S. et al., Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest. 95, 2601-2610 (1995).
31. Kaneda, Y., Iwai, K., & Uchida, T. Introduction and expression of the human insulin gene in adult rat liver. J. Biol. Chem. 264, 12126-12129 (1989).